Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sodium Hyaluronate
Therapeutic Area : Ophthalmology
Study Phase : Approved FDF
Sponsor : Fidia Farmaceutici Spa
Deal Size : Undisclosed
Deal Type : Acquisition
Fidia Farmaceutici enters the UK market with the acquisition of Altacor Ltd
Details : Through the acquisition, Fidia strengthen its positioning in a strategically important therapeutic area with a growing portfolio of products including Clinitas, a dedicated line for dry eye treatment.
Product Name : Clinitas
Product Type : Miscellaneous
Upfront Cash : Undisclosed
September 03, 2025
Lead Product(s) : Sodium Hyaluronate
Therapeutic Area : Ophthalmology
Highest Development Status : Approved FDF
Sponsor : Fidia Farmaceutici Spa
Deal Size : Undisclosed
Deal Type : Acquisition
Lead Product(s) : ALT005
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Antimicrobial Efficacy of ALT005 Ophthalmic Prep Solution in Healthy Volunteers
Details : ALT005 is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Surgical Wound Infection.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 13, 2012
Lead Product(s) : ALT005
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
